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SORE THROAT IN PRIMARY CARE
There are still problems in identifying who will develop
complications of sore throat in primary care
Jan Matthys general practitioner, lecturer in general practice
University of Ghent, University Hospital, 1K6, 9000 Ghent, Belgium
In Little and colleagues’ study of the predictors of suppurative
complications for acute sore throat in primary care, “complicated
illness” was an exclusion criterion.1 Indeed, in guidelines from
the Netherlands and Belgium,2 antibiotics are recommended
only in very ill and high risk patients (immunocompromised),
who comprise about 5% of patients with sore throat in general
practice. I assume that this is what the authors meant by
“complicated illness” or “safety netting.”
Little and colleagues suggest that inflammatory markers such
as C reactive protein might help predict suppurative
complication but not all studies agree.
To control possible complications or to manage uncertainty, the
authors and the linked editorial suggest a “delayed prescription”
strategy. However, a Cochrane review indicated that such a
strategy reduced antibiotic use compared with immediate
antibiotic prescribing in respiratory infections, but that most
studies found that complication rates were no different from
those seen with a “no antibiotics” prescribing strategy.3
I agree with the authors and editorial that doctors overestimate
patients’ expectations of an antibiotic prescription. A Belgian
study found that most people with sore throat visit their doctor
for reassurance and pain relief—hopes of an antibiotic ranked
only 11th of 13 items.4 And another study found a reduction in
new antibiotic prescriptions when patients had the opportunity
to express their expectations (reassurance, pain relief) or
concerns.5
Unfortunately, history, scores, examination, and tests cannot
identify those who will develop complications, as Little and
colleagues seem to conclude. Perhaps further research into
antibiotic prescribing strategies should focus on identifying
patient groups at high risk of complications,3 enhancing doctors’
communication with patients to maintain satisfaction, and
investigating how to reduce doctors’ anxieties about not
prescribing antibiotics for sore throat.3 5
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